Studies have shown that the expression of CD28 in the peripheral blood of patients with malignant lung tumors is significantly decreased (70), which indicates that the abnormal costimulatory pathway leads to the decrease of immune function in the body and is closely related to the occurrence and development of tumors. This evidence concerns the gene CD28 and lung cancer.